Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 14, 2016Studies show that treatment is less costly and has lower hospital re-admissions
Boston Scientific Corporation (NYSE: BSX) today announced that its GreenLight XPS™ Laser Therapy System, used for the treatment of prostatic enlargement, known as benign prostatic hyperplasia...
-
Jun 8, 2016Accelerates momentum to bring differentiated value to patients and health care systems
Boston Scientific Corporation (NYSE: BSX) today announced a global restructuring program to build on the progress the company has made in executing long-term growth strategies and bringing...
-
May 26, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Goldman Sachs Global Healthcare Conference on June 9 in Rancho Palos Verdes. Dan Brennan, executive vice president and...
-
May 24, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Jefferies 2016 Healthcare Conference on June 7, in New York City. Susie Lisa, vice president, Investor Relations, will...
-
May 19, 2016Full-Body MRI Access Expands Spinal Cord Stimulation Offering and Brings Customized Therapy to More Patients Suffering from Chronic Pain
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Precision Montage™ MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug...
-
May 13, 2016
Boston Scientific (NYSE: BSX) today announced the schedule of key data that will be featured at the annual EuroPCR Scientific Program, May 17-20 in Paris. Data from the 1,000-patient EWOLUTION...
-
May 6, 2016Late-Breaker Data Presented at HRS Scientific Sessions Is Most Extensive Post-Market Study for S-ICD
Boston Scientific (NYSE: BSX) today announced results from the largest post-market registry for the Subcutaneous Implantable Defibrillator (S-ICD) System. Data collected from the EFFORTLESS study...
-
May 3, 2016New catheters and software enhancement expand capabilities of high-definition Rhythmia™ Mapping System
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used with the Rhythmia™ Mapping System. The IntellaNav™ XP and the...
-
Apr 29, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2016 Health Care Conference on May 12, in Las Vegas. Dan Brennan, executive vice...
-
Apr 28, 2016Late-Breaking Clinical Trial Session Features Subcutaneous Implantable Defibrillator Data
Boston Scientific (NYSE: BSX) today announced key data, including one late-breaking clinical trial, that will be featured at the 37th Annual Scientific Sessions of the Heart Rhythm Society (HRS)...
-
Apr 27, 2016
Boston Scientific Corporation (NYSE: BSX) generated sales of $1.964 billion during the first quarter ended March 31, 2016, compared to the company's guidance range for the quarter of $1.890 to...
-
Apr 25, 2016FDA approval includes ACCOLADE™ MRI and ESSENTIO™ MRI pacemakers and INGEVITY™ MRI pacing leads
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for a suite of products deemed safe for use in a magnetic resonance imaging (MRI) environment. The...
-
Apr 21, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Deutsche Bank 41st Annual Health Care Conference on May 5, in Boston. Dan Brennan, executive vice president and chief...
-
Apr 20, 2016European Approval Granted for Third-Generation System and All Previously Implanted, Second-Generation Systems
Boston Scientific (NYSE: BSX) has received CE Mark approval for the new EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System, as well as magnetic resonance (MR) conditional labeling...
-
Apr 8, 2016
Boston Scientific (NYSE: BSX) has initiated a global, voluntary recall of all models of its Fetch™ 2 Aspiration Catheter, a thrombectomy catheter used during procedures to remove small blood...
-
Apr 1, 2016
Boston Scientific does not use “counterfeit” or “adulterated” materials in our medical devices. The company rejects the allegations in the petition to the Food and Drug Administration...
-
Apr 1, 2016
Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2016 on Wednesday, April 27,...
-
Mar 29, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 15th Annual Needham Healthcare Conference on April 12, in New York City. Susie Lisa, vice president, Investor...
-
Mar 24, 2016
Boston Scientific (NYSE: BSX) today announced key data presentations spanning its interventional cardiology, rhythm management and structural heart portfolios, that will be featured at the...
-
Mar 22, 2016
Boston Scientific Corporation (NYSE: BSX) today announced the launch of the AXIOS™ Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complications from...
-
Mar 16, 2016
Boston Scientific Corporation (NYSE: BSX) and Mayo Clinic today announced a continuing collaboration where the two organizations share intellectual property and stimulate the rapid development of...
-
Mar 10, 2016FDA approval granted on the heels of CE Mark for the IntellaTip MiFi™ open-irrigated catheter
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Blazer™ Open-Irrigated (OI) radiofrequency ablation catheter. The Blazer OI catheter has been...
-
Mar 1, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Barclays Global Health Care Conference on March 15, in Miami Beach. Dan Brennan, executive vice president and chief...
-
Feb 25, 2016Chairman Pete Nicholas to retire; President and CEO Mike Mahoney to become chairman
Boston Scientific Corporation (NYSE: BSX) announced today a number of changes to the leadership and membership of its Board of Directors. Pete M. Nicholas, the company's co-founder and chairman of...
-
Feb 23, 2016
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen & Co. 36th Annual Health Care Conference on March 8, in Boston. Dan Brennan, executive vice president and chief...